T helper 17 (TH17) cells comprise a recently identified TH-cell lineage that has a pro-inflammatory role in autoimmunity and tissue inflammation. Now, three groups report that the cytokine interleukin-21 (IL-21) is not only produced by TH17 cells but is also a potent and necessary inducer of TH17-cell differentiation.

The differentiation of TH17 cells is initiated by transforming growth factor-β (TGFβ) and IL-6, and IL-23 is additionally required for TH17-cell differentiation in vivo. The transcription factors signal transduction and activator of transcription 3 (STAT3) and retinoic-acid-receptor-related orphan receptor-γ (RORγ) mediate lineage commitment.

Using gene-expression analysis, Nurieva and colleagues compared TH17 cells with the other known TH-cell subsets (TH1 and TH2 cells) and found that expression of Il21 mRNA was significantly higher in TH17 cells compared with the other effector cells. They next investigated how IL-21 expression is regulated in TH17 cells and found that it is upregulated in response to IL-6 but not to TGFβ or IL-23. IL-21 expression was severely impaired in STAT3-deficient cells, but cells lacking RORγ produced similar levels of IL-21 compared with wild-type T cells. So, IL-21 expression by TH17 cells is dependent on STAT3, whereas IL-17 expression is dependent on both STAT3 and RORγ. Similar results were also obtained by Zhou and colleagues.

In vitro stimulation experiments showed that IL-21-deficient T cells were defective in differentiating into TH17 cells and this was associated with enhanced differentiation of cells expressing the transcription factor forkhead box P3 (FOXP3), which is associated with the generation of regulatory T cells (TReg cells). Further experiments suggested that IL-21 is acting in an autocrine manner, as does interferon-γ (IFNγ) for TH1 cells and as does IL-4 for TH2 cells. Finally, when the authors induced experimental autoimmune encephalomyelitis (EAE; a disease in which TH17 cells are known to be pathogenic) in IL-21-deficient mice, they found that the lack of IL-21 impaired the generation of TH17 cells and ameliorated the disease.

Previous work from Vijay Kuchroo's group had suggested a reciprocal relationship in the generation of TH17 cells versus TReg cells, in which IL-6 is pivotal in controlling TH17-cell-lineage specification. In the present study, when Korn and colleagues crossed IL-6-deficient mice with green-fluorescent-protein-labelled FOXP3 knock-in mice and EAE was induced, TH17 cells did not develop but the mice had higher numbers of CD4+CD25+FOXP3+ TReg cells, which was in line with their predictions. As it was possible that the IL-6-deficient environment led to the expansion of TReg cells at the expense of effector T cells, the authors deleted TReg cells in IL-6-deficient mice and expected to observe induction of autoimmunity mediated by IFNγ-producing TH1 cells but not TH17 cells. As expected, these TReg-cell-depleted mice were susceptible to EAE. However, they unexpectedly found that IL-17 production was almost similar to wild-type levels, suggesting that TH17 cells could be generated in vivo in the absence of IL-6. By testing a number of candidate cytokines that could suppress the TGFβ-mediated induction of FOXP3 expression, the authors showed that IL-21 in combination with TGFβ could suppress both FOXP3 expression and induce IL-17 production in naive T cells. However, the frequency of TH17 cells induced by TGFβ plus IL-21 was lower than that stimulated by TGFβ plus IL-6. Further experiments led the authors to suggest that TGFβ and IL-6 together initiate the differentiation of TH17 cells, which then produce IL-21 and this creates an amplification loop for further generation of TH17 cells.

The experiments conducted by Zhou and colleagues yielded similar data — they found that IL-6 induced STAT3-dependent but RORγt-independent expression of IL-21. IL-21 then acts in a self-amplifying loop and cooperates with TGFβ in a RORγt-dependent pathway to induce IL-17 production. IL-21 production also induces expression of the IL-23 receptor, enabling the IL-23 that is produced by antigen-presenting cells to act together with TGFβ to induce the expression of IL-17 and other cytokines.

Together these studies reveal a role for IL-21 in the generation of TH17 cells and suggest that IL-21, together with IL-6 and IL-23, might be new targets for the therapy of inflammatory diseases.